Françoise Kraeber-Bodéré

基本信息

Career Trajectory

Bio

Françoise Kraeber-Bodéré was particularly involved in the last ten years in the design of translational research programs and multicenter clinical trials evaluating innovative radiopharmaceuticals in oncology in close collaboration with industrial partners and cooperative groups. These trials have demonstrated the clinical benefits of radioimmunotherapy in lymphoma, leading in 2009 to a "Victoires de la médecine" in oncology.

Research Interests

Papers共 411 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

The contest between internal and external-beam dosimetry: The Zeno's paradox of Achilles and the tortoise

Francesco Cicone,Katarina Sjogreen Gleisner,Anna Sarnelli,Luca Indovina,Jonathan Gear,Silvano Gnesin,Francoise Kraeber-Bodere,Angelika Bischof Delaloye,Vincenzo Valentini,Marta Cremonesi

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2024): 103188-103188

Cited1Views0WOSBibtex

Dosimetry for Targeted Radionuclide Therapy in Routine Clinical Practice: Experts Advice Vs. Clinical Evidence

Arnaud Dieudonné,Clément Bailly,Florent Cachin,Agathe Edet-Sanson,Françoise Kraeber-Bodéré,Sébastien Hapdey,Charles Merlin,Philippe Robin,Pierre-Yves Salaun, Paul Schwartz,David Tonnelet,Pierre Vera,Frédéric Courbon,Thomas Carlier

European journal of nuclear medicine and molecular imagingno. 4 (2024): 947-950

Cited0Views0WOSBibtex

Pilot Feasibility Study: 18 F-DPA-714 PET/CT Macrophage Imaging in Triple-Negative Breast Cancers (EITHICS)

Caroline Rousseau,Raphael Metz,Olivier Kerdraon, Lobna Ouldamer,Florence Boiffard, Karine Renaudeau,Ludovic Ferrer,Johnny Vercouillie,Isabelle Doutriaux-Dumoulin,Alexis Mouton,Maelle Le Thiec,Agnes Morel,Daniela Rusu,Maria-Joao Santiago-Ribeiro,Loic Campion,Nicolas Arlicot,Francoise Kraeber-Bodere

CLINICAL NUCLEAR MEDICINEno. 8 (2024): 701-708

Cited0Views0WOSBibtex

Abstract PO2-06-13: Promising clinical performance of 89Zirconium-labelled Girentuximab PET-CT for imaging metastatic triple negative breast cancer patients (OPALESCENCE)

Caroline Rousseau,Marie Francoise Heymann,Jean Sebastien FRENEL, Elise Picot-Dilly,Maelle Le Thiec, Manon Taupin,Alexis Mouton,Emmanuelle Bourbouloux,Agnès Morel,Nadia Allam,Amélie Mallet,Mario Campone,Ludovic Ferrer,Françoise Kraeber-Bodéré

Cancer Researchno. 9_Supplement (2024): PO2-06

Cited0Views0Bibtex

Survival Impact of [225Ac]ac-Dotatoc Alpha-Therapy in a Preclinical Model of Pancreatic Neuroendocrine Tumor Liver Micrometastases

Alexandre Lugat,Nicolas Chouin, Florian Chocteau, Mathilde Esnault,Séverine Marionneau-Lambot,Sébastien Gouard,Éric Frampas,Alain Faivre-Chauvet,Mickaël Bourgeois,Alfred Morgenstern,Frank Bruchertseifer,Michel Chérel,Françoise Kraeber-Bodéré,Catherine Ansquer,Joëlle Gaschet

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING（2024）

Cited0Views0WOSBibtex

DCE-MRI to Distinguish All Monoclonal Plasma Cell Disease Stages and Correlation with Diffusion-Weighted MRI/PET-based Biomarkers in a Hybrid Simultaneous Whole Body-2-[18f]fdg-pet/mri Imaging Approach

Bastien Jamet,Hatem Necib,Thomas Carlier,Eric Frampas, Juliette Bazin, Paul-Henri Desfontis,Aurélien Monnet,Caroline Bodet-Milin,Philippe Moreau,Cyrille Touzeau,Francoise Kraeber-Bodere

CANCER IMAGING（2024）

Cited0Views0WOSBibtex

EANM Guidelines on the Use of [18F]FDG PET/CT in Diagnosis, Staging, Prognostication, Therapy Assessment, and Restaging of Plasma Cell Disorders

Cristina Nanni,Christophe M. Deroose,Sona Balogova,Constantin Lapa,Nadia Withofs,Manil Subesinghe,Bastien Jamet,Elena Zamagni,Davide Ippolito,Michel Delforge,Francoise Kraeber-Bodéré

European Journal of Nuclear Medicine and Molecular Imagingpp.1-22, (2024)

Cited0Views0WOSBibtex

Validation of the ΔSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial

Emmanuel Itti,Paul Blanc-Durand,Alina Berriolo-Riedinger,Salim Kanoun,Francoise Kraeber-Bodere,Michel Meignan,Elodie Gat,Steven Le Gouill,Rene-Olivier Casasnovas,Caroline Bodet-Milin

Journal of Nuclear Medicineno. 11 (2023): 1706-1711

Cited0Views0WOSBibtex

Low Tmtv Influences Response and Outcomes in R/R DLBCL 3L+ Patients Treated with CAR-T Cells : First Results of FDG-PET/CT Analysis in the French Descar-T Registry

Yassine Al Tabaa,Clément Bailly, Xavier Pallard,Anne Ségolène Cottereau,Jérémie Tordo,Pierre Sesques,Guillaume Cartron,Roch Houot,Roberta Di Blasi,Salim Kanoun, Caroline Milin,Françoise Kraeber-Bodéré,Laetitia Vercellino

Bloodno. Supplement 1 (2023): 3019-3019

Cited0Views0Bibtex

Performance of PET/CT using [¹⁸F]Fludarabine for initial staging and therapeutic evaluation of symptomatic multiple myeloma (MM) patients in first line treatment or first relapse : preliminary results of an exploratory multicenter phase 2 study

C. Francois,M. Santiago-Ribeiro,B. Jamet,S. Guillouet,C. Perrio, A. Abbas,F. Gourand,S. Querellou,T. Chalopin,C. Dubegny,C. Touzeau, N. Blin,F. Kraeber-Bodere,C. Bodet-Milin

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGINGno. SUPPL 1 (2023): S46-S47

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Head of the Nuclear Medicine Department

Papers共 411 篇Author StatisticsCo-AuthorSimilar Experts